EUVIMEDEUVIMED entdecken
Open Access

Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine

A Ghodousi, I Iannucci, F Saluzzo, J Dreisbach, S Mirold-Mei, M Hoelscher, D M Cirillo

IJTLD Open · 2025-10 · 2 (10) · 604-609

DOI: 10.5588/ijtldopen.25.0301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IJTLD Open, online erschienen am 01.10.2025. Verfasst von A Ghodousi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vita-Salute San Raffaele University, Milan, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis complex (MTBC) remain a significant global health challenge. This study investigates resistance mechanisms to BTZ-043, a novel decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1) inhibitor, and its potential cross-resistance with bedaquiline (BDQ) and clofazimine (CFZ). METHODS BTZ-043-resistant mutants were generated in M. tuberculosis H37Rv by serial exposure to escalating drug concentrations. Minimum inhibitory concentrations (MICs) for BTZ-043 were determined for 130 wild-type strains, including 60 H37Rv independent cultures and 70 diverse clinical isolates, plus 33 non–wild-type clinical strains with known BDQ susceptibility. MICs were correlated with whole-genome sequencing (WGS) data to identify genetic factors underlying resistance. RESULTS The MIC distribution for clinical MTBC strains was similar to the reference strain, with a mode of 0.002 μg/mL. WGS of resistant mutants revealed mutations in dprE1 and Rv0678 . Rv0678 and dprE1 mutations resulted in 4- to 8-fold and >1,000-fold increase in MIC compared with the reference mode, respectively. Sequential clinical strains from BDQ-treated patients showed increased MICs and Rv0678 mutations, indicating low-level cross-resistance. However, Rv0678 mutations in BDQ-susceptible strains did not affect BTZ-043 MICs. CONCLUSION Rv0678 mutations confer low-level cross-resistance to BTZ-043, BDQ, and CFZ, with variable effects on susceptibility. These findings highlight the complexity of resistance mechanisms and the need for ongoing surveillance and early resistance assessments in drug development.

Schlagwörter

Stichwörter der Autor:innen

MDR-TBMICWGSextensively drug-resistantmultidrug-drug resistanttuberculosis

Autor:innen und Institutionen

  • Vita-Salute San Raffaele University, Milan, Italy.
  • IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
  • German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, Munich, Germany.
  • Unit Global Health, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.

Zitieren

APA

Ghodousi, A., Iannucci, I., Saluzzo, F., Dreisbach, J., Mirold-Mei, S., Hoelscher, M., & Cirillo, D. M. (2025). Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine. IJTLD Open, 2(10), 604-609. https://doi.org/10.5588/ijtldopen.25.0301

Vancouver

Ghodousi A, Iannucci I, Saluzzo F, Dreisbach J, Mirold-Mei S, Hoelscher M, et al. Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine. IJTLD Open. 2025;2(10):604-609. doi:10.5588/ijtldopen.25.0301

BibTeX
@article{Ghodousi2025,
  author = {Ghodousi, A and Iannucci, I and Saluzzo, F and Dreisbach, J and Mirold-Mei, S and Hoelscher, M and Cirillo, D M},
  title = {Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine},
  journal = {IJTLD Open},
  year = {2025},
  volume = {2},
  number = {10},
  pages = {604--609},
  doi = {10.5588/ijtldopen.25.0301}
}
Kostenlos starten →